| NEUMORA NEUMORA THERAPEUTICS, INC
90574634 11 Mar 2021 | on 25 Jun 2024
| Research and development of pharmaceutical preparations and substances... Class 042 Class 042 Computer & Software Services & Scientific Services Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; Analyzing genetic, genomic, biological and clinical data for scientific research purposes; Analyzing genetic, genomic, biological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies | | | NEUMORA NEUMORA THERAPEUTICS, INC.
90574644 11 Mar 2021 | on 25 Jun 2024
| Research and development of pharmaceutical preparations and substances... Class 005 Class 005 Pharmaceutical Products House mark used for pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders Class 042 Class 042 Computer & Software Services & Scientific Services Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; Analyzing genetic, genomic, biological and clinical data for scientific research purposes; Analyzing genetic, genomic, biological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies | | | BLACKTHORN THERAPEUTICS NEUMORA THERAPEUTICS, INC.
87028297 06 May 2016 | on 14 Jul 2020
| Marketing of pharmaceutical preparations for the treatment of brain di... Class 035 Class 035 Advertising, Business & Retail Services Color is not claimed as a feature of the mark. Class 042 Class 042 Computer & Software Services & Scientific Services BLACK THORN THERAPEUTICS | | | GEMINI-DOT NEUMORA THERAPEUTICS, INC.
87667042 31 Oct 2017 | on 04 Sep 2018
| Computer software for interpretation of brain scans provided by diagno... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Color is not claimed as a feature of the mark. | | | GEMINI-DOT NEUMORA THERAPEUTICS, INC.
87667040 31 Oct 2017 | on 04 Sep 2018
| Computer software for interpretation of brain scans provided by diagno... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software for interpretation of brain scans provided by diagnostic imaging equipment; computer software for mapping the intersection of gene expression and neurological imaging | | | LYVLISO Neumora Therapeutics, Inc.
98290659 29 Nov 2023 | on 16 Dec 2024 | Pharmaceutical preparations and substances for the treatment, manageme... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders | | | HAPRULO Neumora Therapeutics, Inc.
98290658 29 Nov 2023 | on 02 Oct 2024 | Pharmaceutical preparations and substances for the treatment, manageme... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders | | | PALRIZU Neumora Therapeutics, Inc.
98290651 29 Nov 2023 | on 02 Oct 2024 | Pharmaceutical preparations and substances for the treatment, manageme... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders | | | PRECISION PHENOTYPE NEUMORA THERAPEUTICS, INC.
90356587 03 Dec 2020 | on 19 Aug 2024 | Pharmaceutical preparations and substances for the treatment, manageme... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders Class 042 Class 042 Computer & Software Services & Scientific Services Medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data; medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data for the development and treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies Class 044 Medical, Beauty & Agricultural Services "PHENOTYPE" | | | NEUMORA NEUMORA THERAPEUTICS, INC.
90577585 13 Mar 2021 | on 10 Jun 2024 | Research and development of pharmaceutical preparations and substances... Class 005 Class 005 Pharmaceutical Products The color(s) light green and dark blue is/are claimed as a feature of the mark. Class 042 Class 042 Computer & Software Services & Scientific Services Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; Analyzing genetic, genomic, biological and clinical data for scientific research purposes; Analyzing genetic, genomic, biological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies | | 
